These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8615657

  • 1. Endometrial cancer cell lines are sensitive to paclitaxel.
    Rantanen V, Grénman S, Kulmala J, Grénman R.
    Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.
    Engblom P, Rantanen V, Kulmala J, Grènman S.
    Anticancer Res; 1996; 16(4A):1743-7. PubMed ID: 8712694
    [Abstract] [Full Text] [Related]

  • 3. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
    Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R.
    Anticancer Res; 1997; 17(2A):939-43. PubMed ID: 9137431
    [Abstract] [Full Text] [Related]

  • 4. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P, Rantanen V, Kulmala J, Heiskanen J, Grenman S.
    Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
    [Abstract] [Full Text] [Related]

  • 5. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
    Tam KF, Ng TY, Tsang PC, Li CF, Ngan HY.
    J Soc Gynecol Investig; 2006 Oct; 13(7):518-22. PubMed ID: 16979354
    [Abstract] [Full Text] [Related]

  • 6. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
    Shibata K, Kikkawa F, Kondo C, Mizokami Y, Kajiyama H, Ino K, Nomura S, Mizutani S.
    Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
    [Abstract] [Full Text] [Related]

  • 7. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y, Li JD, Shi HL, Liu JH, Feng YL, Li MD.
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [Abstract] [Full Text] [Related]

  • 8. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M.
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
    Niero A, Emiliani E, Monti G, Pironi F, Turci L, Valenti AM, Marangolo M.
    Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
    [Abstract] [Full Text] [Related]

  • 10. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
    Hidaka T, Nakamura T, Shima T, Yuki H, Saito S.
    J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT, Sevin BU.
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [Abstract] [Full Text] [Related]

  • 12. Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer.
    Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Gynecol Oncol; 1999 Jun; 73(3):422-3. PubMed ID: 10366471
    [Abstract] [Full Text] [Related]

  • 13. [Chemosensitivity test for 170 human breast carcinoma samples].
    He Z, Yuan J, Chen Z, Liu S, Shen Z, Fei H.
    Hunan Yi Ke Da Xue Xue Bao; 1998 Jun; 23(6):531-4. PubMed ID: 10806759
    [Abstract] [Full Text] [Related]

  • 14. Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.
    Erjala K, Raitanen M, Kulmala J, Grénman R.
    Anticancer Res; 2005 Jun; 25(6B):4363-7. PubMed ID: 16309241
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL, Watson JM, Gehrig PA, Fowler WC, Haskill JS.
    Cancer Res; 1999 May 15; 59(10):2425-32. PubMed ID: 10344753
    [Abstract] [Full Text] [Related]

  • 16. [Dose response curve of paclitaxel measured by histoculture drug response assay].
    Yoshimasu T, Oura S, Hirai I, Kokawa Y, Okamura Y, Furukawa T.
    Gan To Kagaku Ryoho; 2005 Apr 15; 32(4):497-500. PubMed ID: 15853216
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    Sonnemann J, Gänge J, Pilz S, Stötzer C, Ohlinger R, Belau A, Lorenz G, Beck JF.
    BMC Cancer; 2006 Jul 11; 6():183. PubMed ID: 16834771
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 11; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 19. In vitro chemosensitivity testing of human non-small cell lung cancer cell lines.
    Bepler G, O'Briant K.
    Anticancer Res; 1998 Jun 11; 18(5A):3181-5. PubMed ID: 9858881
    [Abstract] [Full Text] [Related]

  • 20. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
    Erjala K, Pulkkinen J, Kulmala J, Alanen K, Grenman R.
    Anticancer Res; 2002 Jun 11; 22(6A):3135-42. PubMed ID: 12530056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.